Leaflet LOGIMAX 50mg / 5mg prolonged-release tablets


Indicated for: hypertension

Substance: metoprolol + felodipine (beta blocker + calcium channel blocker)

ATC: C07EBN1 (Cardiovascular system | Beta blocking agents and vasodilators | Beta blocking agents, selective, and vasodilators)

The combination of metoprolol and felodipine is used for the treatment of hypertension and angina pectoris. This combination combines a beta-blocker (metoprolol) and a calcium channel blocker (felodipine) to lower blood pressure and improve blood flow to the heart.

Metoprolol helps slow the heart rate and reduce the heart's oxygen demand, while felodipine relaxes blood vessels, making it easier for blood to circulate. This combination is effective in preventing cardiovascular complications such as myocardial infarction.

The medication is usually taken once daily, and the dose should be adjusted based on the patient's response. It is important to follow the doctor's instructions and not to stop the treatment abruptly.

Side effects may include dizziness, fatigue, or peripheral edema. Patients with severe heart failure or allergies to any of the medication's components should avoid its use.

General data about LOGIMAX 50mg / 5mg

  • Substance: metoprolol + felodipine
  • Date of last drug list: 01-07-2015
  • Commercial code: W01849001
  • Concentration: 50mg / 5mg
  • Pharmaceutical form: prolonged-release tablets
  • Quantity: 30
  • Product type: original
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.